BI 2536 Second Line Monotherapy in SCLC

Clinical trial NCT00412880 · COMPLETED

Trial details

NCT number: NCT00412880
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Small Cell

Start date: 2007-02-14
Primary completion: 2008-06-30
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.